Captopril clinical trials angiotensin-Converting Enzyme Inhibitors

Lopirin - Capoten - SQ14225 - SQ 14225 - SQ-14225 - SQ14534 - SQ 14534 - SQ-14534

Acute myocardial infarction

Patients with left ventricular dysfunction after MI :  5 trials  - Sogaard - SAVE - Mortarino - Pfeffer - Sharpe

Patients with or without HF:  19 trials  - French - Di Pasquale - ECCE - CATS - CCS-1 - ISIS-4 - Di Pasquale - PRACTICAL (captopril) - Sogaard - Galcera - Ray - Bussmann - Hargreaves - SAVE - Nabel - Sharpe - Mortarino - Pfeffer - Sharpe

Systematic early treatment (with or without sign of HF):  14 trials  - French - Di Pasquale - ECCE - CATS - CCS-1 - ISIS-4 - Di Pasquale - PRACTICAL (captopril) - Galcera - Ray - Bussmann - Hargreaves - Nabel - Sharpe

Diabetes type 2

All type of patients:  3 trials  - CAPP (diabetic subgroup) - UKPDS 38 - UKPDS 39

Patients with hypertension:  3 trials  - CAPP (diabetic subgroup) - UKPDS 38 - UKPDS 39

Patients with or without hypertension:  3 trials  - CAPP (diabetic subgroup) - UKPDS 38 - UKPDS 39

Heart failure

All type of heart failure:  9 trials  - Cilazapril-Captopril Multi-centre Group (capt vs pbo) - Munich MHFT (Kleber) - Barabino - Magnani - Captopril Digoxin Multicenter Research Group - Bussmann - Magnani - packer - CMRG

Elderly :  1 trials  - Barabino

MI patients with LV dysfunction without clinical evidence of HF:  5 trials  - Sogaard - SAVE - Mortarino - Pfeffer - Sharpe

Hypertension

All diseases requiring ACEi (HF, CHD, HT,...):  1 trials  - VALIANT/Val+Cap

All type of patient:  2 trials  - CAPPP - UKPDS-HDS

Diabetic patients :  3 trials  - CAPP (diabetic subgroup) - UKPDS 38 - UKPDS 39